feedback

Course Director

Robert Dreicer, MD, MS, FACP, FASCO
Robert Dreicer, MD, MS, FACP, FASCO

University of Virginia Cancer Center
University of Virginia School of Medicine
Charlottesville, Virginia

Faculty

Fred Saad
Fred Saad, MD, FRCS

University of Montreal Hospital Center (CHUM)
Montreal, Quebec, Canada

Tomasz M. Beer
Tomasz M. Beer, MD

OHSU Knight Cancer Institute
Portland, Oregon

Raoul S. Concepcion
Raoul S. Concepcion, MD, FACS

Urology Associates, Nashville
Nashville, Tennessee

Accredited by

Penn State College of Medicine

Activity Details

Credit Types:CME
Credit Amount:2.0 Credits
Release Date:2016-Jun-30
Expiration Date:2017-Jun-29
Estimated Time for Completion:120 minutes
Registration Required:No
Cost:Free of Charge

Activity Description and Educational Objectives

The treatment of patients with prostate cancer must be individualized based upon the most recent clinical evidence; guidelines/consensus recommendations; relevant patient-, tumor-, and treatment-related factors; and each patient’s specific needs and preferences. In addition, optimal care of patients with prostate cancer requires effective collaboration and coordination of care among different specialists throughout the disease continuum. In this engaging CME-certified activity, four urology and oncology experts review the most recent therapeutic advances in early-stage and advanced prostate cancer and use a series of real case scenarios to discuss the nuances of developing individualized, evidence-based treatment plans for patients with prostate cancer, as well as the best practices for effective interdisciplinary collaboration among urologists and oncologists to ensure that all patients with prostate cancer receive the best treatment at the right time.

Upon completion of this activity, participants should be better able to:

  • Describe current and planned prostate cancer clinical trials assessing hormone, cytotoxic, immunologic, bone-directed, and other novel therapies in different early-stage and advanced disease settings and patient populations
  • Evaluate the latest data on the efficacy, safety, and roles of approved and investigational therapies and novel combinations for prostate cancer
  • Develop individualized, evidence-based treatment plans for patients with prostate cancer
  • Implement strategies for effective interdisciplinary collaboration and coordination of care to ensure that each patient with prostate cancer receives the best treatment at the most appropriate time

Target Audience

This activity has been designed to meet the educational needs of urologists and other clinicians who manage patients with prostate cancer.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: Month June 30, 2016 - June 29, 2017
Time to Complete: 120 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director

Robert Dreicer, MD, MS, FACP, FASCO
Section Head Medical Oncology
Deputy Director, University of Virginia Cancer Center
Associate Director for Clinical Research
Co-Director Paul Mellon Urologic Cancer Institute
Professor of Medicine and Urology
University of Virginia School of Medicine
Charlottesville, Virginia

Robert Dreicer, MD, MS, FACP, FASCO, has a financial interest/relationship or affiliation in the form of:
Consultant for Asana BioSciences, LLC.; Churchill Pharmaceuticals LLC; Ferring Pharmaceuticals Inc.; Medivation, Inc.; and Tokai Pharmaceuticals, Inc.

Faculty

Fred Saad, MD, FRCS
Professor and Chief of Urology
Director of Genitourinary Oncology
U of M Endowed Chair in Prostate Cancer Research
University of Montreal Hospital Center (CHUM)
Montreal, Quebec, Canada

Fred Saad, MD, FRCS, has a financial interest/relationship or affiliation in the form of:
Consultant for Amgen Inc.; Astellas Pharma Canada, Inc.; Bayer Inc.; Janssen Inc.; and Sanofi.
Grant/Research Support from Amgen Inc.; Astellas Pharma Canada, Inc.; Bayer Inc.; Janssen Inc.; and Sanofi.

Tomasz M. Beer, MD
Professor of Medicine, Hematology & Medical Oncology
Deputy Director, OHSU Knight Cancer Institute
Portland, Oregon

Tomasz M. Beer, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for AstraZeneca; Churchill Pharmaceuticals LLC; and F. Hoffmann-La Roche Ltd.
Grant/Research Support from Astellas Pharma US, Inc.; Bristol-Myers Squibb; Dendreon Corporation; Janssen Pharmaceuticals, Inc.; Medivation, Inc.; OncoGenex Pharmaceuticals Inc.; and SOTIO.

Raoul S. Concepcion, MD, FACS
Director of Advanced Therapeutics
Urology Associates, Nashville
Nashville, Tennessee

Raoul S. Concepcion, MD, FACS, has a financial interest/relationship or affiliation in the form of:
Consultant for Bayer Corporation and Dendreon Corporation.
Speakers Bureau participant with Amgen Inc.; Astellas Pharma US, Inc.; Bayer Corporation; Dendreon Corporation; Genomic Health; Janssen Pharmaceuticals, Inc.; Medivation, Inc.; sanofi-aventis U.S. LLC.; and Tokai Pharmaceuticals, Inc.

Medical Director

Kadrin Wilfong, MD
PVI, PeerView Institute for Medical Education

Kadrin Wilfong, MD, has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G5945-16-T.

Providership

This CME activity is jointly provided by Penn State College of Medicine and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by independent educational grants from AbbVie, Astellas Pharma Global Development, LLC Medical Affairs, Americas US and Medivation, Inc., Ferring Pharmaceuticals, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Sanofi US; and Tokai Pharmaceuticals, Inc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.

Copyright © 2000-2016, PeerView Press - Medical Education Resource

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.